Your browser doesn't support javascript.
loading
Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation study.
Ogura, Michinori; Imaizumi, Yoshitaka; Uike, Naokuni; Asou, Norio; Utsunomiya, Atae; Uchida, Toshiki; Aoki, Tomohiro; Tsukasaki, Kunihiro; Taguchi, Jun; Choi, Ilseung; Maruyama, Dai; Nosaka, Kisato; Chen, Nianhang; Midorikawa, Shuichi; Ohtsu, Tomoko; Tobinai, Kensei.
Afiliação
  • Ogura M; Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital, Aichi, Japan; Department of Hematology, Tokai Central Hospital, Higashijimacho, Sohara, Kakamigahara, Gifu, Japan. Electronic address: mi-ogura@naa.att.ne.jp.
  • Imaizumi Y; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
  • Uike N; Department of Hematology, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Japan; Department of Palliative Care, Saga-Ken Medical Centre, Koseikan, Saga, Japan.
  • Asou N; Department of Hematology, Kumamoto University Hospital, Kumamoto, Japan; Department of Hematology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Utsunomiya A; Department of Hematology, Imamura Bun-in Hospital, Kagoshima, Japan.
  • Uchida T; Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital, Aichi, Japan.
  • Aoki T; Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital, Aichi, Japan; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Aichi, Japan.
  • Tsukasaki K; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan; Department of Hematology, National Cancer Center Hospital East, Chiba, Japan.
  • Taguchi J; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
  • Choi I; Department of Hematology, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Japan.
  • Maruyama D; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Nosaka K; Cancer Center, Kumamoto University Hospital, Aichi, Japan; Department of Therapeutics Development and Clinical Research Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Chen N; Celgene Corporation, Summit, NJ, USA.
  • Midorikawa S; Celgene KK, Tokyo, Japan.
  • Ohtsu T; Celgene KK, Tokyo, Japan.
  • Tobinai K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Lancet Haematol ; 3(3): e107-18, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26947199
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Talidomida / Leucemia-Linfoma de Células T do Adulto / Linfoma de Células T Periférico / Inibidores da Angiogênese Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Talidomida / Leucemia-Linfoma de Células T do Adulto / Linfoma de Células T Periférico / Inibidores da Angiogênese Idioma: En Ano de publicação: 2016 Tipo de documento: Article